Reported Reactions

Devices › Device types

FDA product code DXE · class 2 · Cardiovascular

Catheter, embolectomy: medical device reports filed with FDA

7,789 reports carry this product code, 1992–2026; 16 brands with a page.

7,789
reports with this product code
0% of all MAUDE reports
468
reports, 12 months to August 2026
307 in the 12 months before
80.1%
classified as malfunction
62.3% across all reports
1.8%
classified as death, as reported
0.9% across all reports

Product code DXE is FDA's classification for "Catheter, embolectomy" (cardiovascular panel), a class 2 device. 7,789 medical device reports carry this product code, 0% of the MAUDE database, from January 1992 to August 2026.

468 reports arrived in the 12 months to August 2026, up 52% from 307 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (80.1%), injury (14.4%) and other (3.2%). 16 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Fogarty Arterial Embolectomy Catheter1,155370.2%87.4%
AngioJet SOLENT omni609261.3%93.1%
Fogarty Thru-Lumen Embolectomy Catheter426760.7%95.8%
Indigo System Aspiration Catheter 639600%97.2%
TufTex Over-the-Wire Embolectomy Catheter3601590%99.7%
Angiojet Zelantedvt24805.3%76.3%
Indigo System Aspiration Catheter 816921.5%90.8%
Indigo System Separator 812241.9%75.8%
Indigo System Catrx Aspiration Catheter96110%90.7%
AngioJet SOLENT Proxi3354.6%84.6%
AdvanCE3182.7%72.7%
Pruitt F3 Carotid Shunt23730.3%92.9%
Internal Hex Implant200%0%
Galileo100.1%97.6%
Penumbra System Jet7 Reperfusion Catheter104%81.5%
Ruby Coil1260.1%95.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Edwards Lifesciences Pr1,59720.5%
Penumbra1,30316.7%
Boston Scientific - Maple Grove92911.9%
Lemaitre Vascular82610.6%
Arrow International3764.8%
Edwards Lifesciences3073.9%
Applied Medical Resources1992.6%
Arrow Intl1752.2%
Medos International Sarl1161.5%
Vascular Solutions871.1%
Applied Medical550.7%
Boston Scientific530.7%
Medtronic440.6%
Ev3320.4%
Merit Medical Systems150.2%

Reports by month, five years

03773Sep 2021: 20Oct 2021: 27Nov 2021: 17Dec 2021: 272022Jan 2022: 23Feb 2022: 26Mar 2022: 30Apr 2022: 15May 2022: 18Jun 2022: 19Jul 2022: 36Aug 2022: 65Sep 2022: 67Oct 2022: 73Nov 2022: 56Dec 2022: 352023Jan 2023: 58Feb 2023: 48Mar 2023: 27Apr 2023: 41May 2023: 31Jun 2023: 33Jul 2023: 29Aug 2023: 31Sep 2023: 26Oct 2023: 49Nov 2023: 29Dec 2023: 342024Jan 2024: 46Feb 2024: 44Mar 2024: 34Apr 2024: 32May 2024: 15Jun 2024: 26Jul 2024: 34Aug 2024: 27Sep 2024: 40Oct 2024: 19Nov 2024: 35Dec 2024: 252025Jan 2025: 36Feb 2025: 24Mar 2025: 24Apr 2025: 26May 2025: 12Jun 2025: 14Jul 2025: 29Aug 2025: 23Sep 2025: 39Oct 2025: 31Nov 2025: 35Dec 2025: 172026Jan 2026: 18Feb 2026: 25Mar 2026: 43Apr 2026: 51May 2026: 30Jun 2026: 66Jul 2026: 60Aug 2026: 53

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1.8%143
Injury14.4%1,118
Malfunction80.1%6,240
Other3.2%250
Not given0.5%38

Who filed

Manufacturer report93%7,247
Voluntary report2.8%217
User facility report0%0
Distributor report0.1%5
Not given4.1%320

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Breakthe device broke98812.7%
Material rupture91811.8%
Aspiration issue5016.4%
Material deformation4716%
Device displays incorrect message4545.8%
Material separation4475.7%
Material fragmentation4415.7%
Detachment of device component3854.9%
Deflation problem3073.9%
Detachment of device or device componentpart of the device came off2983.8%
Kinkedthe tube or line kinked2453.1%
Physical resistance/sticking2182.8%
Difficult to removethe device was hard to remove2022.6%
Leak/splashthe device leaked1992.6%
Device damaged prior to usethe device was damaged before use1782.3%
Suction problem1632.1%
Burst container or vessel1612.1%
Tip breakage1552%
Failure to advance1431.8%
Physical resistance1431.8%

Questions about catheter, embolectomy reports

What is product code DXE?

FDA's classification code for "Catheter, embolectomy", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

7,789 reports through August 2026, 468 of them in the latest 12 months.

Which brands appear most often?

Fogarty Arterial Embolectomy Catheter (1,155), AngioJet SOLENT omni (609), Fogarty Thru-Lumen Embolectomy Catheter (426), Indigo System Aspiration Catheter 6 (396) and TufTex Over-the-Wire Embolectomy Catheter (360). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.